InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Gulfo Adele M., 董事. Officer active across 4 companies, notably Enpro Industries, INC. In total, 8 reports have been recorded. History available since 15 February 2022. The latest transaction was filed on 12 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Gulfo Adele M. is a Director at Enpro Inc., NewAmsterdam Pharma Co N.V., Myovant Sciences Ltd., and Enpro Industries, INC. The declarant has 8 filings in total, and across the 8 sampled filings, the activity observed between 2022-02-16 and 2026-02-12 is Attribution, with amounts of EUR 117882.4834154065, EUR 116467.8157328594, EUR 102810.0226386659, and EUR 97265.15496632013 in the top filings shown.